Free Trial
→ America dodged a crisis — next time it could be much worse (From Weiss Ratings) (Ad) Free YMAB Stock Alerts

Y-mAbs Therapeutics (YMAB) SEC Filings & 10K Form

$13.82
-0.17 (-1.22%)
(As of 09/6/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends

Recent Y-mAbs Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/12/2024
6:06 AM		Y-mAbs Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
5:50 AM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
3:15 PM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
4:29 PM		PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:59 PM		PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2024
3:20 PM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
8:00 PM		TYAGI ASHU (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:00 PM		GILL DAVID N (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:01 PM		HEALY JAMES (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:01 PM		Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:02 PM		Hamill Laura (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:02 PM		TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:05 PM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
6:53 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:54 PM		Ber Gerard (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:44 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
8:36 PM		Kruse Bo (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
5:54 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:42 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2024
4:04 PM		Y-mAbs Therapeutics (Filer)
Form DEFA14A
04/29/2024
4:05 PM		Y-mAbs Therapeutics (Filer)
Form ARS
04/29/2024
4:09 PM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
4:09 PM		Paradigm Biocapital Advisors LP (Filed by)
Y-mAbs Therapeutics (Subject)
Form SC 13G
03/14/2024
4:01 PM		TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
8:17 AM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
5:17 AM		TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2024
4:02 PM		Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:49 PM		Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
3:40 PM		Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:05 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
5:05 AM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
4:04 PM		Y-mAbs Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/06/2024
2:59 PM		ACORN BIOVENTURES, L.P. (Filed by)
Y-mAbs Therapeutics (Subject)
Form SC 13G/A
01/22/2024
4:54 PM		Lund-Hansen Torben (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
4:56 PM		Wilms Joris (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
4:58 PM		Lisby Steen (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
5:00 PM		Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
5:02 PM		Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
4:48 PM		Kruse Bo (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
4:52 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
5:45 AM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Fmr CIA Advisor reveals PEACEMAKER superweapon (Ad)

Kamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.

Full details are in this announcement.
12/26/2023
3:15 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
6:40 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:40 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
7:27 AM		WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
7:26 AM		Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
4:25 PM		Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
4:25 PM		WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
4:14 PM		Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
4:15 PM		WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
4:14 PM		WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
4:15 PM		Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
3:47 PM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
4:15 PM		Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2023
4:16 PM		Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
4:19 PM		Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
3:09 PM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
8:00 AM		Y-mAbs Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:YMAB) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners
Perfect Crypto Buying Opportunity for 50 Cents
When cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...
Crypto 101 Media | Sponsored
The solution to fast food’s wage hike crisis
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...
Deal Maker | Sponsored
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳
45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...
Mode Mobile | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Say Goodbye to the US Dollar
The warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...
Sasco Gold LLC | Sponsored
Elon Musk’s chilling warning for humanity
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...
The Freeport Society | Sponsored
These 5 stocks could soar after November 4th
How to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...
StockEarnings | Sponsored
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...
Paradigm Press | Sponsored